331 related articles for article (PubMed ID: 25128329)
1. OX26/CTX-conjugated PEGylated liposome as a dual-targeting gene delivery system for brain glioma.
Yue PJ; He L; Qiu SW; Li Y; Liao YJ; Li XP; Xie D; Peng Y
Mol Cancer; 2014 Aug; 13():191. PubMed ID: 25128329
[TBL] [Abstract][Full Text] [Related]
2. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals.
Ying X; Wen H; Lu WL; Du J; Guo J; Tian W; Men Y; Zhang Y; Li RJ; Yang TY; Shang DW; Lou JN; Zhang LR; Zhang Q
J Control Release; 2010 Jan; 141(2):183-92. PubMed ID: 19799948
[TBL] [Abstract][Full Text] [Related]
3. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
[TBL] [Abstract][Full Text] [Related]
4. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.
Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q
J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361
[TBL] [Abstract][Full Text] [Related]
5. Targeted delivery of chlorotoxin-modified DNA-loaded nanoparticles to glioma via intravenous administration.
Huang R; Ke W; Han L; Li J; Liu S; Jiang C
Biomaterials; 2011 Mar; 32(9):2399-406. PubMed ID: 21185076
[TBL] [Abstract][Full Text] [Related]
6. Use of PEGylated Immunoliposomes to Deliver Dopamine Across the Blood-Brain Barrier in a Rat Model of Parkinson's Disease.
Kang YS; Jung HJ; Oh JS; Song DY
CNS Neurosci Ther; 2016 Oct; 22(10):817-23. PubMed ID: 27350533
[TBL] [Abstract][Full Text] [Related]
7. Glioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomes.
Gao JQ; Lv Q; Li LM; Tang XJ; Li FZ; Hu YL; Han M
Biomaterials; 2013 Jul; 34(22):5628-39. PubMed ID: 23628475
[TBL] [Abstract][Full Text] [Related]
8. Active targeting of orthotopic glioma using biomimetic liposomes co-loaded elemene and cabazitaxel modified by transferritin.
Li J; Zeng H; You Y; Wang R; Tan T; Wang W; Yin L; Zeng Z; Zeng Y; Xie T
J Nanobiotechnology; 2021 Sep; 19(1):289. PubMed ID: 34565383
[TBL] [Abstract][Full Text] [Related]
9. Polyethylenimine-based theranostic nanoplatform for glioma-targeting single-photon emission computed tomography imaging and anticancer drug delivery.
Zhao L; Zhu J; Gong J; Song N; Wu S; Qiao W; Yang J; Zhu M; Zhao J
J Nanobiotechnology; 2020 Oct; 18(1):143. PubMed ID: 33054757
[TBL] [Abstract][Full Text] [Related]
10. A novel RGDyC/PEG co-modified PAMAM dendrimer-loaded arsenic trioxide of glioma targeting delivery system.
Lu Y; Han S; Zheng H; Ma R; Ping Y; Zou J; Tang H; Zhang Y; Xu X; Li F
Int J Nanomedicine; 2018; 13():5937-5952. PubMed ID: 30323584
[TBL] [Abstract][Full Text] [Related]
11. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma.
Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X
Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting.
Liu Y; Ran R; Chen J; Kuang Q; Tang J; Mei L; Zhang Q; Gao H; Zhang Z; He Q
Biomaterials; 2014 Jun; 35(17):4835-47. PubMed ID: 24651033
[TBL] [Abstract][Full Text] [Related]
13. CTX-CNF1 Recombinant Protein Selectively Targets Glioma Cells In Vivo.
Vannini E; Mori E; Tantillo E; Schmidt G; Caleo M; Costa M
Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33800135
[TBL] [Abstract][Full Text] [Related]
14. A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood-brain barrier, and the transporting mechanism to glioma cells.
Liu C; Liu XN; Wang GL; Hei Y; Meng S; Yang LF; Yuan L; Xie Y
Int J Nanomedicine; 2017; 12():2407-2425. PubMed ID: 28405164
[TBL] [Abstract][Full Text] [Related]
15. Efficient Anti-Glioma Therapy Through the Brain-Targeted RVG15-Modified Liposomes Loading Paclitaxel-Cholesterol Complex.
Xin X; Liu W; Zhang ZA; Han Y; Qi LL; Zhang YY; Zhang XT; Duan HX; Chen LQ; Jin MJ; Wang QM; Gao ZG; Huang W
Int J Nanomedicine; 2021; 16():5755-5776. PubMed ID: 34471351
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor radiopharmaceuticals: 111In chelation, conjugation to a blood-brain barrier delivery vector via a biotin-polyethylene linker, pharmacokinetics, and in vivo imaging of experimental brain tumors.
Kurihara A; Deguchi Y; Pardridge WM
Bioconjug Chem; 1999; 10(3):502-11. PubMed ID: 10346884
[TBL] [Abstract][Full Text] [Related]
17. Retention of biologic activity of human epidermal growth factor following conjugation to a blood-brain barrier drug delivery vector via an extended poly(ethylene glycol) linker.
Deguchi Y; Kurihara A; Pardridge WM
Bioconjug Chem; 1999; 10(1):32-7. PubMed ID: 9893961
[TBL] [Abstract][Full Text] [Related]
18. Imaging endogenous gene expression in brain cancer in vivo with 111In-peptide nucleic acid antisense radiopharmaceuticals and brain drug-targeting technology.
Suzuki T; Wu D; Schlachetzki F; Li JY; Boado RJ; Pardridge WM
J Nucl Med; 2004 Oct; 45(10):1766-75. PubMed ID: 15471847
[TBL] [Abstract][Full Text] [Related]
19. Liposomal formulations of carboplatin injected by convection-enhanced delivery increases the median survival time of F98 glioma bearing rats.
Shi M; Anantha M; Wehbe M; Bally MB; Fortin D; Roy LO; Charest G; Richer M; Paquette B; Sanche L
J Nanobiotechnology; 2018 Oct; 16(1):77. PubMed ID: 30290821
[TBL] [Abstract][Full Text] [Related]
20. Liposomes Combined an Integrin αvβ3-Specific Vector with pH-Responsible Cell-Penetrating Property for Highly Effective Antiglioma Therapy through the Blood-Brain Barrier.
Shi K; Long Y; Xu C; Wang Y; Qiu Y; Yu Q; Liu Y; Zhang Q; Gao H; Zhang Z; He Q
ACS Appl Mater Interfaces; 2015 Sep; 7(38):21442-54. PubMed ID: 26371468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
